The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease

被引：424
|
作者：
Cookson, Mark R. [1 ]
机构：
[1] NIA, Neurogenet Lab, NIH, Bethesda, MD 20982 USA
来源：
NATURE REVIEWS NEUROSCIENCE | 2010年 / 11卷 / 12期
基金：
美国国家卫生研究院;
关键词：
AUTOSOMAL-DOMINANT PARKINSONISM; ALPHA-SYNUCLEIN; LEUCINE-RICH-REPEAT-KINASE-2; LRRK2; CYTOPLASMIC LOCALIZATION; 14-3-3; BINDING; ROC DOMAIN; MUTATIONS; PROTEIN; PHOSPHORYLATION; GENE;
D O I：
10.1038/nrn2935
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Parkinson's disease, like many common age-related conditions, is now recognized to have a substantial genetic component. Here, I discuss how mutations in a large complex gene-leucine-rich repeat kinase 2 (LRRK2) - affect protein function, and I review recent evidence that LRRK2 mutations affect pathways that involve other proteins that have been implicated in Parkinson's disease, specifically a-synuclein and tau. These concepts can be used to understand disease processes and to develop therapeutic opportunities for the treatment of Parkinson's disease.
引用
收藏
页码：791 / 797
页数：7
相关论文
共 50 条
  • [31] Dyskinesias in patients with Parkinson's disease: Effect of the leucine-rich repeat kinase 2 (LRRK2) G2019S mutation
    Yahalom, Gilad
    Kaplan, Natalie
    Vituri, Aya
    Cohen, Oren S.
    Inzelberg, Rivka
    Kozlova, Evgenia
    Korczyn, Amos D.
    Rosset, Saharon
    Friedman, Eitan
    Hassin-Baer, Sharon
    PARKINSONISM & RELATED DISORDERS, 2012, 18 (09) : 1039 - 1041
  • [32] Generation of fourteen isogenic cell lines for Parkinson's disease-associated leucine-rich repeat kinase (LRRK2)
    Beylina, Aleksandra
    Langston, Rebekah G.
    Rosen, Dorien
    Reed, Xylena
    Cookson, Mark R.
    STEM CELL RESEARCH, 2021, 53
  • [33] Leucine-rich repeat kinase 2 (LRRK2) deficiency diminishes the development of EAU
    Wandu, Sylvia
    Shi, Guangpu
    Ogbeifun, Osato
    Nugent, Lindsey
    Cai, Huaibin
    Gery, Igal
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [34] Leucine-rich repeat kinase 2 (LRRK2) regulates α-synuclein clearance in microglia
    Maekawa, Tatsunori
    Sasaoka, Toshikuni
    Azuma, Sadahiro
    Ichikawa, Takafumi
    Melrose, Heather L.
    Farrer, Matthew J.
    Obata, Fumiya
    BMC NEUROSCIENCE, 2016, 17
  • [35] Leucine-rich repeat kinase 2 (LRRK2) regulates α-synuclein clearance in microglia
    Tatsunori Maekawa
    Toshikuni Sasaoka
    Sadahiro Azuma
    Takafumi Ichikawa
    Heather L. Melrose
    Matthew J. Farrer
    Fumiya Obata
    BMC Neuroscience, 17
  • [36] Characterization of Autophosphorylation in the Leucine-Rich Repeat Kinase 2 (LRRK2) GTPase Domain
    West, A.
    Webber, P. J.
    Smith, A.
    Sen, S.
    Biskup, S.
    Yue, Z.
    Mobley, J. A.
    Horton, B.
    MOVEMENT DISORDERS, 2010, 25 : S611 - S611
  • [37] A review of modifiers of Parkinsonism in the Leucine-rich repeat kinase 2 (LRRK2) population
    Staisch, J.
    MOVEMENT DISORDERS, 2018, 33 : S622 - S622
  • [38] Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration
    Smith, WW
    Pei, Z
    Jiang, HB
    Moore, DJ
    Liang, YD
    West, AB
    Dawson, VL
    Dawson, TM
    Ross, CA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (51) : 18676 - 18681
  • [39] Targeting leucine-rich repeat kinase 2 in Parkinson's disease
    Chan, Sharon L.
    Angeles, Dario C.
    Tan, Eng-King
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (12) : 1471 - 1482
  • [40] Leucine-rich repeat kinase 2: Relevance to Parkinson's disease
    Guo, Luxuan
    Wang, Wen
    Chen, Shu G.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2006, 38 (09): : 1469 - 1475
12345